About NETRI
NETRI is a company based in Lyon (France) founded in 2018 by Florian Larramendy and Thibault Honegger. NETRI has raised $8.89 million across 2 funding rounds from investors including Bpifrance, Neovacs and Polygone. NETRI offers products and services including Organs-on-Chip Kits, Licensing Programs, and NeuroFluidics Devices. NETRI operates in a competitive market with competitors including Emulate, CN Bio, AxoSim, Mimetas and Obatala Sciences, among others.
- Headquarter Lyon, France
- Founders Florian Larramendy, Thibault Honegger
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$8.89 M (USD)
in 2 rounds
-
Latest Funding Round
Not available
-
Investors
Bpifrance
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NETRI
NETRI offers a comprehensive portfolio of products and services, including Organs-on-Chip Kits, Licensing Programs, and NeuroFluidics Devices.
Kits for in-house platforms to culture and analyze cells.
Programs for technology transfer and internal assays.
Devices for 2D and 3D cell culture and data recording.
People of NETRI
Unlock access to complete
Funding Insights of NETRI
NETRI has successfully raised a total of $8.89M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in NETRI
NETRI has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Bpifrance, Neovacs and Polygone.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Offers rental and sale of residential properties across French departments.
|
Locked | Locked | Locked | |
|
Offers domain name registration and hosting services for businesses.
|
Locked | Locked | Locked |
Investor details for NETRI
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NETRI
Investment portfolio details for NETRI
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - NETRI
Detailed financials for NETRI
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Netri Comparisons
Peer comparison for NETRI
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of NETRI
NETRI operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Emulate, CN Bio, AxoSim, Mimetas and Obatala Sciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of in vitro models for drug development
|
|
| Locked | Locked | Locked |
Organ-on-a-chip platforms are developed for drug discovery applications.
|
|
| Locked | Locked | Locked |
Nerve-on-a-chip technology is advanced by AxoSim for drug development improvement.
|
|
| Locked | Locked | Locked |
Microfluidics-based organ-on-a-chip models for drug evaluation are developed.
|
|
| Locked | Locked | Locked |
Provider of research enabling products and services to research centers
|
|
| Locked | Locked | Locked |
Small human tissue segments are generated in microfluidic chips.
|
Detailed competitors of NETRI
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Netri
Complete news archive for NETRI
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NETRI
NETRI was founded in 2018 and raised its 1st funding round 4 years after it was founded.
NETRI is headquartered in Lyon, France. It is registered at Lyon, Auvergne-rhone-alpes, France.
Thibault Honegger is the current CEO of NETRI. They have also founded this company.
NETRI is a funded company, having raised a total of $8.89M across 2 funding rounds to date.
NETRI was founded in 2018 in Lyon, France, as a developer of microfluidic devices targeted at industrial applications. The companys NeoBento platform is utilized to create next-generation 3D brain-on-a-chip models, which support research into treatments for neurological diseases. Operations are centered in the biotechnology sector, with a focus on advancing in vitro modeling techniques for pharmaceutical and medical applications. Co-founders include Florian Larramendy and Thibault Honegger, who serves as CEO.
NETRI offers Organs-on-Chip Kits, Licensing Programs, and NeuroFluidics Devices.